Stock Pick (US) - Novo Nordisk A/S - First-Mover Edge in Oral Weight-Loss Therapy
Stock Pick (US) - Novo Nordisk A/S - First-Mover Edge in Oral Weight-Loss Therapy
On this page
NVO is a global pharmaceutical leader specializing in diabetes care and obesity treatment, with operations in over 170 countries worldwide.
